# Cyproheptadine Hydrochloride

NDC: 16571-805
Generic name: Cyproheptadine Hydrochloride
Labeler / Manufacturer: Rising Pharma Holdings, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20220209

FDA application: ANDA207555

## Active ingredients

- CYPROHEPTADINE HYDROCHLORIDE: 4 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"16571-805"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=16571-805
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c5e9e983-d0d2-4f87-beae-0d853ca43983